Chengda Biotech announced that the company plans to cancel 2.982,400 repurchased shares originally used for employee stock ownership plans or equity incentives to reduce registered capital. The matter has been reviewed and approved by the board of directors and the extraordinary shareholders' meeting. After the cancellation is completed, the total share capital of the company will be changed from 416 million shares to 413 million shares, and the registered capital will be changed from 416 million yuan to 413 million yuan accordingly. The repurchase of the remaining 2.6578 million shares in the special account will still be used for employee stock ownership plans or equity incentives. The company's creditors have the right to demand that the company settle their debts or provide corresponding guarantees within 30 days from the date of receipt of the notice, and those that have not received the notice within 45 days from the date of disclosure of the notice.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.